ClinicalTrials.gg
RecruitingNCT07134543Updated Dec 23, 2025

Using the Smart Underwear Device to Determine a Baseline of Flatus Activity Normalized to Fiber Intake

An observational study in All Health Backgrounds to Determine a Baseline of Flatus Activity, sponsored by University of Maryland, College Park. Recruiting at 2 sites in United States. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-12-23.

Sponsored by University of Maryland, College Park · Observational

From the registry’s dates

  • Started Dec 2025; still recruiting 11 months later.
Study type
Observational
Model
Ecologic or community
Time perspective
Prospective
Enrollment
500
Ages
18 Years and older
Sex
All
01

Study summary

The goal of this observational study is to quantify the typical frequency of flatulence in healthy adults, normalized by fiber intake, using the Smart Underwear device. The study will enroll a maximum of 500 adults across the United States who will wear the device for three consecutive days while continuing their usual daily activities.

The main questions it aims to answer are:

  • What is the average frequency of flatus events in a general adult population?
  • How does dietary fiber intake influence flatus frequency and microbiome activity?

Researchers will collect gas sensor data from the Smart Underwear device alongside dietary information logged in a mobile app to assess the relationship between diet and microbiome activity.

Participants will:

  • Complete an online eligibility survey, consent form, and background questionnaire.
  • Wear the Smart Underwear device for at least 12 hours per day for three consecutive days.
  • Log all meals with photos using a custom smartphone app.
  • Complete a short post-wear survey about device comfort and usability.

All study procedures will be conducted remotely. Data will be analyzed in de-identified form to evaluate baseline flatulence patterns, normalized to fiber intake, in the general adult population.

02

Conditions studied

  • All Health Backgrounds to Determine a Baseline of Flatus Activity

Browse trials for

03

In context

Flatulence

42 studies on the registry are indexed under Flatulence; 7 are open to participants now.

Browse Flatulence studies →

Lead sponsor

University of Maryland, College Park is the lead sponsor of 62 studies on the registry; 15 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Residents of the US

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • 18 years old or older
  • Lives in the US
  • Is not pregnant or lactating
  • Is willing to wear the Smart Underwear device as instructed in the study procedures

Exclusion criteria

Exclusion Criteria:

  • Younger than 18 years old
  • Lives outside the US
  • Is pregnant or lactating
  • Is not willing to wear the Smart Underwear device as instructed in the study procedures
05

Study design

Observational model
Ecologic or community
Time perspective
Prospective
Enrollment
500 participants (estimated)
Patient registry
No

Groups and cohorts

  • American adults

    American adults that are at least 18 years old, live in the United States, are not pregnant or lactating, and agree to wear the Smart Underwear device.

06

What researchers measure

Primary outcomes

  1. Microbiome Activity Index

    The Microbiome Activity Index is a composite measure reflecting gut microbiome activity, calculated from both flatus frequency and hydrogen gas concentration. The index uses the absolute value of the first derivative of the hydrogen sensor signal to better capture flatus intensity, reduce baseline noise, and mitigate sensor saturation at high hydrogen levels. This composite approach ensures a more accurate representation of gut microbiome activity than relying on flatus count or hydrogen concentration alone. Data are collected using a wearable device ("Smart Underwear") and uploaded to the Human Flatus Atlas app.

    Time frame: 12 hours each day for 3 days

Secondary outcomes

  1. Total flatus count

    The total number of flatus events detected by the wearable device. Detection is based on hydrogen gas concentration changes and signal rate-of-change analysis.

    Time frame: 12 hours each day for 3 days

  2. Flatus Per Hour

    The rate of flatus events normalized per hour, calculated from the total number of events and the total monitored time.

    Time frame: 12 hours each day for 3 days

  3. Microbiome Activity Index Comparative Score

    A relative score comparing the participant's Microbiome Activity Index to aggregated anonymized results from other individuals in the Human Flatus Atlas study. Presented as a percentile rank or standardized score.

    Time frame: 12 hours each day for 3 days

  4. Fiber-Normalized Flatus Frequency

    The participant's flatus frequency (events/day) normalized by self-reported dietary fiber intake (grams/day). Normalization will allow assessment of typical adult flatulence frequency in relation to fiber consumption.

    Time frame: 12 hours each day for 3 days

07

Study locations

1 of 2 sites recruiting
  • Bioscience Research Building
    College Park, Maryland 20742, United States
    Not yet recruiting
  • University of Maryland Bioscience Research Building
    College Park, Maryland 20742, United States
    Recruiting
08

References and documents

Individual participant data

Plan to share: Yes — We plan to share de-identified, aggregate individual participant data limited to total enrollment numbers and demographic characteristics (e.g., age range, sex distribution, and other baseline variables) collected during the study. No other data, including outcome or clinical data, will be shared. Supporting Information The shared dataset will not contain any information that could directly or indirectly identify participants. Data will be available in aggregate format only, and will be provided upon reasonable request from qualified researchers for the purposes of scientific transparency and verification of study population characteristics.

Supporting information: Study protocol

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Dec 23, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07134543
Lead sponsor
University of Maryland, College Park
Responsible party
Sponsor
First posted
Aug 21, 2025
Start date
Dec 1, 2025
Primary completion
Sep 5, 2026 (estimated)
Completion
Dec 1, 2026 (estimated)
Last update
Dec 23, 2025

Study contacts

Brantley Hall, PhD
Contact
brantley@umd.edu
5407978040

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion